Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors

NCT04659603 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

50

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision, the decision is not related to any safety concern.

Conditions

Breast Cancer Metastatic
Pancreatic Carcinoma Metastatic

Interventions

DRUG: tusamitamab ravtansine
DRUG: Gemcitabine

Sponsor

Sanofi